Dr. Robert E. Randolph

Scott Tykodi is an Oncologist in Seattle, Washington. Dr. Tykodi is rated as an Elite provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Adult Soft Tissue Sarcoma, and Nephrectomy. Dr. Tykodi is currently accepting new patients.

Dennis Willerford is an Oncologist and a Hematologist Oncology provider in Poulsbo, Washington. Dr. Willerford is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Waldenstrom Macroglobulinemia, Adult Immune Thrombocytopenia, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC). Dr. Willerford is currently accepting new patients.

"Joseph Rosales, MD, has been a physician for over 20 years and a hematologist-oncologist in Western Washington since 2011 -- in Seattle, Federal Way and Tacoma. He is experienced in general hematology and oncology, with specialties in breast and thoracic oncology. Dr. Rosales considers himself a guide in his patients’ therapeutic journey. He meets his patients wherever they are - physically and emotionally - and strives to provide them the knowledge and perspective required to navigate difficult decisions in their care. His treatment philosophy has been consistent: to make sure that the patient remains in as much control of their care as possible while getting the best care possible.Dr. Rosales also maintains activity within the community, including involvement in oncologic education and advocacy. He received the2022 Binaytara Foundation for Excellence in Cancer Care ""Rising Star in Health Equity"" awardfor his demonstration of excellent leadership in improving cancer care in underprivileged communities.Multidisciplinary Lung Cancer Treatment during Covid-19 Video". Dr. Rosales is rated as a Distinguished provider by MediFind in the treatment of Familial Wilms Tumor 2. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, and Bone Marrow Aspiration.